Alpha-synuclein mRNA expression in oligodendrocytes in MSA. - Test2 - elhamkhani - TriplyDB

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

http://www.wikidata.org/entity/Q34548507

about

Review: Multiple system atrophy: emerging targets for interventional therapies Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders Glia and alpha-synuclein in neurodegeneration: A complex interaction Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.β-III Tubulin fragments inhibit α-synuclein accumulation in models of multiple system atrophy.Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy Alpha-Synuclein Expression in the Oligodendrocyte Lineage: an In Vitro and In Vivo Study Using Rodent and Human Models.Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.Combination therapies: The next logical Step for the treatment of synucleinopathies?Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy Expanding the spectrum of neuronal pathology in multiple system atrophy.Up-regulation of SNCA gene expression: implications to synucleinopathies α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.Neuropathology of multiple system atrophy: new thoughts about pathogenesis.Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?An update on the cerebellar subtype of multiple system atrophy.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Toward disease modification in multiple system atrophy: Pitfalls, bottlenecks, and possible remedies.α-Synuclein and Parkinsonism: Updates and Future Perspectives.ɑ-Synuclein strains and the variable pathologies of synucleinopathies.Multiple system atrophy: pathogenic mechanisms and biomarkers.How strong is the evidence that Parkinson's disease is a prion disorder?Potential Modes of Intercellular α-Synuclein Transmission.Multiple system atrophy: insights into a rare and debilitating movement disorder.Multiple System Atrophy - State of the Art.Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type.Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy.The neuropathology of multiple system atrophy and its therapeutic implications.Multiple system atrophy: experimental models and reality.Discovering the 3' UTR-mediated regulation of alpha-synuclein.Genomic copy number variation analysis in multiple system atrophy.Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.Potential clinical utility of multiple system atrophy biomarkers.Alpha-synuclein levels in patients with multiple system atrophy: a meta-analysis.Immuno-Laser-Capture Microdissection for the Isolation of Enriched Glial Populations from Frozen Post-Mortem Human Brain.

P2860

Q26770919-1C7BF06F-A6B0-4622-88CF-FC72A6345277 Q26779001-977E319B-F890-4D35-BB79-300D3FBB9442 Q26851153-D7E1088C-9E89-4154-8FD5-0A5A0859D1EC Q33805560-E3C9E511-E113-4D80-B36D-5E2AC3EE96D3 Q33991720-872345E7-0FEC-4450-BA40-0EE13E343EF3 Q34107278-006AAE89-4B0F-49D1-AFC8-17046AE7718A Q35544737-D8102EA1-E57E-4B76-A58C-7A6037BD1BCC Q35734100-80216523-0AA2-486F-B659-BC2DD38B5862 Q35952063-D76A42E0-B1D2-4F01-B0C1-08B1821A045B Q36086721-C860E45A-A749-40B0-8426-960247367970 Q36321556-3296E069-D2C3-4E51-A7E8-C880BEB3FDC0 Q36563062-EF81461B-CBDF-4A4E-A7C3-035EBEC58A47 Q36672116-DDECC576-6B82-4ABC-986D-CC60226FA1A2 Q36825501-3FFEF1CA-FBF9-4801-B42D-FDDFB447E2A6 Q37004246-69BC4C5A-BDA3-44F8-8B34-4700C7A95A82 Q37017296-299D2BE8-5D7B-44BF-8299-9E4484D3BD93 Q38258246-30D0A583-3F49-48C1-B6C8-33A35ED42249 Q38475947-4A787D20-7A22-4113-BC3A-4ACA704B6A73 Q38578814-887EEF24-4EA7-47CB-AC98-83BBDBDF693D Q38669105-4099DEB0-FA79-4BF0-9C76-3424E6EF7254 Q38712697-487F1D30-F5F0-4E17-9404-0751FDC4D7AE Q38742153-ED828F9F-7148-41DA-A491-113BF6264C06 Q38753941-9DE1EC2F-5C3E-484B-AF7A-9B13D8566762 Q38813304-E446C8BE-E043-4E25-8B81-6A8EFF0C0C1F Q38852629-AB372762-4DD5-4E6C-808F-EBCA21969056 Q39152836-E1FF9FEB-62BE-46D7-A57F-DB49F6F7D0BF Q39183459-468DFF73-E0D6-450F-88E4-54D519E8EFF2 Q39220912-CDBBF452-CCEA-46D9-A1FA-AA77585F2A6E Q42140713-C199B080-BC93-4E65-BFC2-F4DFE4788756 Q42500238-790EC478-B558-4425-B717-7CD47E5395A4 Q43029332-6B6510FA-84D9-4EEB-B524-CD286FD03D3C Q44618765-481B238A-F275-4B88-9E62-493E19042C15 Q45940520-1BE9D443-EE0B-44CB-8494-935C3C7259C0 Q46726761-18A4B670-310A-4CFD-9E42-E432FC915C4D Q47096637-D6BCB3F4-F6DE-4057-B25A-0FC6BEDFE7A0 Q47099811-E5D41E85-A20B-4319-A247-BDA28B6BC40B Q47252776-B5FE89DA-80D8-4000-AF52-1F70652382D7 Q47663712-57ACB409-B89B-4C3E-87D3-EAFE488CB746 Q47754301-69AD316B-9EAC-465B-AB70-2EFBC1433E84 Q47854651-DF7759EC-6CE5-4D6A-9EA7-5B8619CE509A

P2860

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

http://www.wikidata.org/entity/Q34548507

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

@ast

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

@en

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

@nl

type

label

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

@ast

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

@en

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

@nl

prefLabel

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

@ast

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

@en

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

@nl

P1433

Q34548507-A771FE5A-0BCF-4AC6-97E4-354611EB02DE

P1476

Q34548507-1BC97754-7EB3-4F56-8BFE-CC473446AF81

P2093

Q34548507-1DA8A3C0-61CA-4CF4-97D7-FABD62B8AC15

Q34548507-3AB8D089-B029-4A40-A824-0003E73E9D45

Q34548507-748181DF-6C45-4568-AFAB-24A0F38A2AB2

Q34548507-9F6E7843-B71A-47FD-B2BC-BD4EE0826CDE

Q34548507-A9D9BAE7-8436-49D1-B303-68C62532BA80

Q34548507-DC4297DF-65F7-4491-87B8-98BDCD5A8EB8

Q34548507-E6263A1C-4E29-4E5D-B091-6C6E5986BD38

P2860

Q34548507-0AA5A215-C975-49E9-B8D8-E3F37F5523DF

Q34548507-0E11651E-4A78-4E98-985F-23DD801FDFCC

Q34548507-186839B5-5269-4F74-8296-1C7D26842BA8

Q34548507-1B12985F-3CEA-4513-BFEB-4B82E8EC71BA

Q34548507-1DE2FD74-9303-45DF-9CA2-E402A95F3FF0

Q34548507-2537E5AF-296B-49D9-BECD-E8A68BEBB013

Q34548507-26BE8E75-9522-4AAD-A7D3-B56315AB0E7E

Q34548507-37C1A883-07A6-4B7E-A185-4A06222BFEB8

Q34548507-400AFBEB-4BC7-4C5C-A4EA-9208D54B097F

Q34548507-40FEFC9E-1B4A-4219-BFE7-879CD7BCA535

P304

Q34548507-9D8EFD39-A199-4520-BB02-930F13D326E6

P31

Q34548507-C4708500-5F26-4B04-9CA4-8948EF262B88

P356

Q34548507-EB4E0ED8-1C13-4A4A-B040-8FE3986D932F

P433

Q34548507-0B2D632A-BF2E-4DBB-B197-A2399BB08F40

P478

Q34548507-2CC5CEB7-9B39-496C-B0CE-6BD91809384D

P50

Q34548507-727155DD-5069-41A0-A740-57CA3646712C

P577

Q34548507-8C55035F-13BD-4233-AB0E-470046A19C6C

P5875

Q34548507-47217C4F-483E-4868-8EE6-4D8F11197B48

P698

Q34548507-99791F2C-2F3A-4522-9122-8A91391918FA

P921

Q34548507-8333BCC9-B1E0-4470-9F9C-129D36EF267F

Q34548507-EEAC79F4-4802-4D49-ADA3-D93128D2862B

P932

Q34548507-44927F2A-EEBD-40D1-83AF-C0357E5EC395

P356

P1433

P1476

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

@en

P2093

Henry Houlden

http://www.w3.org/2001/XMLSchema#string

Janice L Holton

http://www.w3.org/2001/XMLSchema#string

Julie E Simpson

http://www.w3.org/2001/XMLSchema#string

Paul R Heath

http://www.w3.org/2001/XMLSchema#string

Stephen B Wharton

http://www.w3.org/2001/XMLSchema#string

Tamas Revesz

http://www.w3.org/2001/XMLSchema#string

Yasmine T Asi

http://www.w3.org/2001/XMLSchema#string

P2860

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Identification of a novel oligodendrocyte cell adhesion protein using gene expression profiling

Multiple system atrophy: a clinical and neuropathological perspective

An anatomically comprehensive atlas of the adult human brain transcriptome

Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies.

Alteration in alpha-synuclein mRNA expression in Parkinson's disease.

Physiology and pathophysiology of alpha-synuclein. Cell culture and transgenic animal models based on a Parkinson's disease-associated protein.

The neuropathology, pathophysiology and genetics of multiple system atrophy.

Isolation of enriched glial populations from post-mortem human CNS material by immuno-laser capture microdissection.

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system.

P304

964-970

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GLIA.22653

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Andrew John Lees

P577

2014-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260485825

http://www.w3.org/2001/XMLSchema#string

P698

24590631

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte

P932

4238782

http://www.w3.org/2001/XMLSchema#string